Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Starch–poly(ε‐caprolactone) and starch–poly(lactic acid) fibre‐mesh scaffolds for bone tissue engineering applications: structure, mechanical properties and degradation behaviour

Open access
Gomes, M. E., Azevedo, H. S., Moreira, A. R., Ellä, V., Kellomäki, M., Reis, R. L. · 2008 · Journal of Tissue Engineering and Regenerative Medicine

Abstract

In scaffold-based tissue engineering strategies, the successful regeneration of tissues from matrix-producing connective tissue cells or anchorage-dependent cells (e.g. osteoblasts) relies on the use of a suitable scaffold. This study describes the development and characterization of SPCL (starch with epsilon-polycaprolactone, 30:70%) and SPLA [starch with poly(lactic acid), 30:70%] fibre-meshes, aimed at application in bone tissue-engineering strategies. Scaffolds based on SPCL and SPLA were prepared from fibres obtained by melt-spinning by a fibre-bonding process. The porosity of the scaffolds was characterized by microcomputerized tomography (microCT) and scanning electron microscopy (SEM). Scaffold degradation behaviour was assessed in solutions containing hydrolytic enzymes (alpha-amylase and lipase) in physiological concentrations, in order to simulate in vivo conditions. Mechanical properties were also evaluated in compression tests. The results show that these scaffolds exhibit adequate porosity and mechanical properties to support cell adhesion and proliferation and also tissue ingrowth upon implantation of the construct. The results of the degradation studies showed that these starch-based scaffolds are susceptible to enzymatic degradation, as detected by increased weight loss (within 2 weeks, weight loss in the SPCL samples reached 20%). With increasing degradation time, the diameter of the SPCL and SPLA fibres decreases significantly, increasing the porosity and consequently the available space for cells and tissue ingrowth during implantation time. These results, in combination with previous cell culture studies showing the ability of these scaffolds to induce cell adhesion and proliferation, clearly demonstrate the potential of these scaffolds to be used in tissue engineering strategies to regenerate bone tissue defects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/term.89

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Atala, 2007, Engineering tissues, organs and cells, J Tissue Eng Regen Med, 1, 83, 10.1002/term.18 · DOI · Paper page
  2. Azevedo, 2003, In vitro assessment of the enzymatic degradation of several starch based biomaterials, Biomacromolecules, 4, 1703, 10.1021/bm0300397 · DOI · Paper page
  3. Azevedo, 2005, Biodegradable Systems in Tissue Engineering and Regenerative Medicine, 177
  4. Catiker, 2000, Degradation of PLA, PLGA homo‐ and copolymers in the presence of serum albumin: a spectroscopic investigation, Polymer Int, 49, 728, 10.1002/1097-0126(200007)49:7<728::AID-PI443>3.0.CO;2-3 · doi:10.1002/1097-0126(200007)49:7<728::aid-pi443>3.0.co;2-3
  5. Chapekar, 2000, Tissue engineering: challenges and opportunities, J Biomed Mater Res Appl Biomater, 53, 617, 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.0.CO;2-C · DOI · Paper page
  6. Chastain, 2006, Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation, J Biomed Mater Res A, 78A, 73, 10.1002/jbm.a.30686 · DOI · Paper page
  7. Chawla, 2002, Biodegradable poly(ε‐caprolactone) nanoparticles for tumor‐targeted delivery of tamoxifen, Int J Pharmaceut, 249, 127, 10.1016/S0378-5173(02)00483-0 · DOI · Paper page
  8. Correlo, 2007, Biomedical Polymers, 197, 10.1533/9781845693640.197 · doi:10.1533/9781845693640.197
  9. De Jong, 2005, Tissue response to partially in vitro predegraded poly‐L‐lactide implants, Biomaterials, 26, 1781, 10.1016/j.biomaterials.2004.06.026 · DOI
  10. Freed, 1998, Culture of organized cell communities, Adv drug Delivery, 33, 15, 10.1016/S0169-409X(98)00017-9 · DOI · Paper page
  11. Freed, 1994, Biodegradable polymer scaffolds for tissue engineering, Biotechnology, 12, 689
  12. Gan, 1997, Enzymatic degradation of poly(ε‐caprolactone) film in phosphate buffer solution containing lipases, Polym Degrad Stabil, 56, 209, 10.1016/S0141-3910(96)00208-X · DOI · Paper page
  13. Gan, 1999, Enzymatic degradation of poly(ε‐caprolactone)/poly(DL‐lactide) blends in phosphate buffer solution, Polymer, 40, 2859, 10.1016/S0032-3861(98)00549-7 · DOI · Paper page
  14. Gomes, 2006, In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor, Tissue Eng, 12, 177, 10.1089/ten.2006.12.177 · DOI
  15. Gomes, 2006, Influence of the porosity of starch‐based fibre‐mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor, Tissue Eng, 12, 801, 10.1089/ten.2006.12.801 · DOI · Paper page
  16. Gomes, 2003, Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch‐based three‐dimensional scaffolds, J Biomed Mater Res A, 67A, 87, 10.1002/jbm.a.10075 · DOI · Paper page
  17. He, 2003, Enzyme‐catalyzed polymerization and degradation of copolymers prepared from ε‐caprolactone and poly(ethylene glycol), Polymer, 44, 5145, 10.1016/S0032-3861(03)00562-7 · DOI · Paper page
  18. Hutmacher, 2000, Scaffolds in tissue engineering bone and cartilage, Biomaterials, 21, 2529, 10.1016/S0142-9612(00)00121-6 · DOI · Paper page
  19. Hutmacher, 2007, State of the art and future directions of scaffold‐based bone engineering from a biomaterials perspective, J Tissue Eng Regen Med, 1, 245, 10.1002/term.24 · DOI · Paper page
  20. Junge, 1989, Evaluation of a new assay for pancreatic amylase—performance characteristics and estimation of reference intervals, Clin Biochem, 22, 109, 10.1016/S0009-9120(89)80007-4 · DOI
  21. Kim, 1998, Development of biocompatible synthetic extracellular matrices for tissue engineering, Trends Biotechnol, 16, 224, 10.1016/S0167-7799(98)01191-3 · DOI · Paper page
  22. Langer, 1999, Selected advances in drug delivery and tissue engineering, J Control Release, 62, 7, 10.1016/S0168-3659(99)00057-7 · DOI
  23. Li, 1999, Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids, J Biomed Mater Res, 48, 342, 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7 · DOI · Paper page
  24. Liu, 2000, Selective enzymatic degradations of poly(L‐lactide) and poly(ε‐caprolactone) blend films, Biomacromolecules, 1, 350, 10.1021/bm000046k · DOI · Paper page
  25. Lu, 1996, The importance of new processing techniques in tissue engineering, MRS Bull Mater Res Soc, 21, 28, 10.1557/S088376940003181X · DOI · Paper page
  26. Maquet, 1997, Design of macroporous biodegradable polymer scaffolds for cell transplantation, Porous Mater Tissue Eng, 250, 15
  27. Mendes, 2003, Evaluation of two biodegradable polymeric systems as substrates for bone tissue engineering, Tissue Eng, 9, S91, 10.1089/10763270360697003 · DOI
  28. Nam, 2000, A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive, J Biomed Mater Res, 53, 1, 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R · DOI · Paper page
  29. Oliveira, 2007, A cartilage tissue engineering approach combining starch–polycaprolactone fibre‐mesh scaffolds with bovine articular chondrocytes, J Mater Sci Mater Med, 18, 295, 10.1007/s10856-006-0692-7 · DOI
  30. Pei, 2002, Bioreactors mediate the effectiveness of tissue engineering scaffolds, FASEB J, 16, 1691, 10.1096/fj.02-0083fje · DOI · Paper page
  31. Pena, 2006, Long‐term degradation of poly(ε‐caprolactone) films in biologically related fluids, Polym Degrad Stabil, 91, 1424, 10.1016/j.polymdegradstab.2005.10.016 · DOI · Paper page
  32. Santos, 2007, Response of micro‐ and macrovascular endothelial cells to starch‐based fibre‐meshes for bone tissue engineering, Biomaterials, 28, 240, 10.1016/j.biomaterials.2006.08.006 · DOI
  33. Thompson, 1995, Biodegradable polymer scaffolds to regenerate organs, Adv Polym Sci, 122, 247
  34. Thompson, 1997, Polymer Scaffold Processing. Principles of Tissue Engineering, 263
  35. Thomson, 1995, Fabrication of biodegradable polymer scaffolds to engineer trabecular bone, J Biomater Sci Polym Ed, 7, 23, 10.1163/156856295X00805 · DOI · Paper page
  36. Tietz, 1993, Lipase in serum—the elusive enzyme—an overview, Clin Chem, 39, 746, 10.1093/clinchem/39.5.746 · DOI · Paper page
  37. Tsuji, 2005, Poly(lactide) stereocomplexes: formation, structure, properties, degradation, and applications, Macromol Biosci, 5, 569, 10.1002/mabi.200500062 · DOI · Paper page
  38. Tsuji, 2006, Enzymatic degradation of biodegradable polyester composites of poly(L‐lactic acid) and poly(ε‐caprolactone), Macromol Mater Eng, 291, 1245, 10.1002/mame.200600276 · DOI
  39. Vacanti, 1999, An overview of tissue engineered bone, Clin Orthop, 367, S375, 10.1097/00003086-199910001-00036 · DOI
  40. Williams, 2005, Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering, Biomaterials, 26, 4817, 10.1016/j.biomaterials.2004.11.057 · DOI · Paper page
  41. Zhang, 1999, Poly(α‐hydroxyl acids) hydroxyapatite porous composites for bone‐tissue engineering. I. Preparation and morphology, J Biomed Mater Res, 44, 446, 10.1002/(SICI)1097-4636(19990315)44:4<446::AID-JBM11>3.0.CO;2-F · DOI · Paper page

Cited by

See all 161

Metadata

Authors
Gomes, M. E., Azevedo, H. S., Moreira, A. R., Ellä, V., Kellomäki, M., & Reis, R. L.
Venue
Journal of Tissue Engineering and Regenerative Medicine
Published
2008-07
Volume
2
Issue
5
Pages
243-252
ISSN
  • 1932-6254 (ISSN-L)
  • 1932-7005
OpenAlex
W2104427836
Cited by
161
References
2
FWCI
9.38
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2618 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.